The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Activated Clotting Time Testing-Global Market Insights and Sales Trends 2024
Synopsis
The activated clotting time (ACT) is a test that is used primarily to monitor high doses of unfractionated (standard) heparin therapy. Heparin is a drug that inhibits blood clotting (anticoagulant) and is usually given intravenously (IV) by injection or continuous infusion. High doses of heparin may be given during procedures that require that blood be prevented from clotting, such as heart bypass surgery.
The global Activated Clotting Time Testing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Activated Clotting Time Testing in various end use industries. The expanding demands from the Hospitals, Clinical Laboratories, Ambulatory Surgical Center and Academic & Research Institutes, are propelling Activated Clotting Time Testing market. Optical Detection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Laser-based Detection segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Activated Clotting Time Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Activated Clotting Time Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Activated Clotting Time Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Activated Clotting Time Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Activated Clotting Time Testing covered in this report include Roche, Thermo Fisher Scientific, Abbott, Helena Laboratories, Sysmex, Medtronic, Instrumentation Laboratory, Diagnostica Stago and Werfen, etc.
The global Activated Clotting Time Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Thermo Fisher Scientific
Abbott
Helena Laboratories
Sysmex
Medtronic
Instrumentation Laboratory
Diagnostica Stago
Werfen
LabCorp
Global Activated Clotting Time Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Activated Clotting Time Testing market, Segment by Type:
Optical Detection
Laser-based Detection
Mechanical Detection
Fluorescent Based Detection
Global Activated Clotting Time Testing market, by Application
Hospitals
Clinical Laboratories
Ambulatory Surgical Center
Academic & Research Institutes
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Activated Clotting Time Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The activated clotting time (ACT) is a test that is used primarily to monitor high doses of unfractionated (standard) heparin therapy. Heparin is a drug that inhibits blood clotting (anticoagulant) and is usually given intravenously (IV) by injection or continuous infusion. High doses of heparin may be given during procedures that require that blood be prevented from clotting, such as heart bypass surgery.
The global Activated Clotting Time Testing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Activated Clotting Time Testing in various end use industries. The expanding demands from the Hospitals, Clinical Laboratories, Ambulatory Surgical Center and Academic & Research Institutes, are propelling Activated Clotting Time Testing market. Optical Detection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Laser-based Detection segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Activated Clotting Time Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Activated Clotting Time Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Activated Clotting Time Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Activated Clotting Time Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Activated Clotting Time Testing covered in this report include Roche, Thermo Fisher Scientific, Abbott, Helena Laboratories, Sysmex, Medtronic, Instrumentation Laboratory, Diagnostica Stago and Werfen, etc.
The global Activated Clotting Time Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Thermo Fisher Scientific
Abbott
Helena Laboratories
Sysmex
Medtronic
Instrumentation Laboratory
Diagnostica Stago
Werfen
LabCorp
Global Activated Clotting Time Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Activated Clotting Time Testing market, Segment by Type:
Optical Detection
Laser-based Detection
Mechanical Detection
Fluorescent Based Detection
Global Activated Clotting Time Testing market, by Application
Hospitals
Clinical Laboratories
Ambulatory Surgical Center
Academic & Research Institutes
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Activated Clotting Time Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Activated Clotting Time Testing
1.1 Activated Clotting Time Testing Market Overview
1.1.1 Activated Clotting Time Testing Product Scope
1.1.2 Activated Clotting Time Testing Market Status and Outlook
1.2 Global Activated Clotting Time Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Activated Clotting Time Testing Market Size by Region (2018-2029)
1.4 Global Activated Clotting Time Testing Historic Market Size by Region (2018-2023)
1.5 Global Activated Clotting Time Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Activated Clotting Time Testing Market Size (2018-2029)
1.6.1 North America Activated Clotting Time Testing Market Size (2018-2029)
1.6.2 Europe Activated Clotting Time Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Activated Clotting Time Testing Market Size (2018-2029)
1.6.4 Latin America Activated Clotting Time Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Activated Clotting Time Testing Market Size (2018-2029)
2 Activated Clotting Time Testing Market by Type
2.1 Introduction
2.1.1 Optical Detection
2.1.2 Laser-based Detection
2.1.3 Mechanical Detection
2.1.4 Fluorescent Based Detection
2.2 Global Activated Clotting Time Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Activated Clotting Time Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Activated Clotting Time Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Activated Clotting Time Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Activated Clotting Time Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Activated Clotting Time Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Activated Clotting Time Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Activated Clotting Time Testing Revenue Breakdown by Type (2018-2029)
3 Activated Clotting Time Testing Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinical Laboratories
3.1.3 Ambulatory Surgical Center
3.1.4 Academic & Research Institutes
3.1.5 Others
3.2 Global Activated Clotting Time Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Activated Clotting Time Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Activated Clotting Time Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Activated Clotting Time Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Activated Clotting Time Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Activated Clotting Time Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Activated Clotting Time Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Activated Clotting Time Testing Revenue Breakdown by Application (2018-2029)
4 Activated Clotting Time Testing Competition Analysis by Players
4.1 Global Activated Clotting Time Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Activated Clotting Time Testing as of 2022)
4.3 Date of Key Players Enter into Activated Clotting Time Testing Market
4.4 Global Top Players Activated Clotting Time Testing Headquarters and Area Served
4.5 Key Players Activated Clotting Time Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Activated Clotting Time Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Roche
5.1.1 Roche Profile
5.1.2 Roche Main Business
5.1.3 Roche Activated Clotting Time Testing Products, Services and Solutions
5.1.4 Roche Activated Clotting Time Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Roche Recent Developments
5.2 Thermo Fisher Scientific
5.2.1 Thermo Fisher Scientific Profile
5.2.2 Thermo Fisher Scientific Main Business
5.2.3 Thermo Fisher Scientific Activated Clotting Time Testing Products, Services and Solutions
5.2.4 Thermo Fisher Scientific Activated Clotting Time Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher Scientific Recent Developments
5.3 Abbott
5.3.1 Abbott Profile
5.3.2 Abbott Main Business
5.3.3 Abbott Activated Clotting Time Testing Products, Services and Solutions
5.3.4 Abbott Activated Clotting Time Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Helena Laboratories Recent Developments
5.4 Helena Laboratories
5.4.1 Helena Laboratories Profile
5.4.2 Helena Laboratories Main Business
5.4.3 Helena Laboratories Activated Clotting Time Testing Products, Services and Solutions
5.4.4 Helena Laboratories Activated Clotting Time Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Helena Laboratories Recent Developments
5.5 Sysmex
5.5.1 Sysmex Profile
5.5.2 Sysmex Main Business
5.5.3 Sysmex Activated Clotting Time Testing Products, Services and Solutions
5.5.4 Sysmex Activated Clotting Time Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Sysmex Recent Developments
5.6 Medtronic
5.6.1 Medtronic Profile
5.6.2 Medtronic Main Business
5.6.3 Medtronic Activated Clotting Time Testing Products, Services and Solutions
5.6.4 Medtronic Activated Clotting Time Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Medtronic Recent Developments
5.7 Instrumentation Laboratory
5.7.1 Instrumentation Laboratory Profile
5.7.2 Instrumentation Laboratory Main Business
5.7.3 Instrumentation Laboratory Activated Clotting Time Testing Products, Services and Solutions
5.7.4 Instrumentation Laboratory Activated Clotting Time Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Instrumentation Laboratory Recent Developments
5.8 Diagnostica Stago
5.8.1 Diagnostica Stago Profile
5.8.2 Diagnostica Stago Main Business
5.8.3 Diagnostica Stago Activated Clotting Time Testing Products, Services and Solutions
5.8.4 Diagnostica Stago Activated Clotting Time Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Diagnostica Stago Recent Developments
5.9 Werfen
5.9.1 Werfen Profile
5.9.2 Werfen Main Business
5.9.3 Werfen Activated Clotting Time Testing Products, Services and Solutions
5.9.4 Werfen Activated Clotting Time Testing Revenue (US$ Million) & (2018-2023)
5.9.5 Werfen Recent Developments
5.10 LabCorp
5.10.1 LabCorp Profile
5.10.2 LabCorp Main Business
5.10.3 LabCorp Activated Clotting Time Testing Products, Services and Solutions
5.10.4 LabCorp Activated Clotting Time Testing Revenue (US$ Million) & (2018-2023)
5.10.5 LabCorp Recent Developments
6 North America
6.1 North America Activated Clotting Time Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Activated Clotting Time Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Activated Clotting Time Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Activated Clotting Time Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Activated Clotting Time Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Activated Clotting Time Testing Market Dynamics
11.1 Activated Clotting Time Testing Industry Trends
11.2 Activated Clotting Time Testing Market Drivers
11.3 Activated Clotting Time Testing Market Challenges
11.4 Activated Clotting Time Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
